Usana Health Sciences USNA Ratios (2009-2026)

NYSE USNA
$13.08 -0.74 (-5.35%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Usana Health Sciences Quarterly Ratios

Periods 71 quarters
Latest Oct 2026

Usana Health Sciences ratios data for the quarter ended Oct 2026. These financial ratios cover 71 quarters of results from Apr 2009 through Oct 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Apr2009 Jul2009 Oct2009 Jan2010 Apr2010 Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Apr2026 Jul2026 Oct2026
Profitability
Gross Margin
81.17%81.28%80.04%80.46%81.81%80.07%81.09%81.05%80.39%81.95%78.98%78.72%77.15%76.25%78.35%
EBT Margin
12.20%11.08%9.95%11.48%11.26%9.62%11.90%9.49%9.29%4.88%6.71%7.98%0.84%6.18%-8.46%
EBIT Margin
12.12%11.10%9.70%10.81%10.24%8.25%10.83%8.38%7.79%3.84%6.28%7.09%0.57%5.54%-8.96%
EBITDA Margin
13.32%12.37%11.19%12.14%11.60%9.79%12.22%10.17%9.57%5.72%9.62%10.37%4.28%8.85%-5.52%
Operating Margin
12.12%11.10%9.70%10.81%10.24%8.25%10.83%8.38%7.79%3.84%6.28%7.09%0.57%5.54%-8.96%
Net Margin
8.23%7.24%6.40%7.40%7.26%5.32%7.26%4.90%5.30%2.09%3.77%4.09%-3.05%3.00%-9.58%
FCF Margin
6.56%2.40%10.95%4.32%2.49%9.74%8.46%6.36%2.50%13.55%1.86%5.08%3.05%-2.41%2.84%9.03%
Efficiency
Inventory AverageInventory Avg.
97.32M97.95M90.87M75.72M67.18M65.79M63.23M61.02M60.77M61.16M61.35M62.91M66.86M71.65M78.41M87.03M91.35M85.21M
Assets AverageAssets Avg.
578.34M575.33M565.44M557.01M576.31M601.04M604.11M601.91M616.95M631.02M630.35M651.36M709.75M747.39M740.56M730.56M721.09M705.84M
Equity AverageEquity Avg.
397.10M392.54M396.81M407.39M422.79M444.91M462.09M469.61M483.80M498.60M506.10M522.65M532.60M530.94M530.41M529.57M534.93M526.53M
Invested CapitalInvested Cap.
395.12M399.95M434.47M497.99M501.31M512.21M533.09M555.11M552.76M531.06M528.07M557.55M526.31M
Asset Utilization RatioAsset Util.
2.072.031.881.701.631.551.491.431.391.321.201.171.211.251.281.27
Leverage & Solvency
Interest Coverage RatioInterest Cover
0.00M305.90707.19865.97567.44409.47474.48349.80318.3963.6438.1364.5524.9857.81
Debt Ratio
0.020.000.000.030.030.02
Times Interest Earned
0.00M305.90707.19865.97567.44409.47474.48349.80318.3963.6438.1364.5524.9857.81
Valuation
Price to EarningsP/E
16.5713.8015.7813.6513.3516.7417.2316.7214.5315.5014.7716.1914.9616.6630.6815.56
Price to SalesP/S
1.281.251.031.191.241.201.111.030.980.840.800.600.630.570.330.430.31
Price to BookP/B
4.973.903.572.622.352.672.592.382.061.851.681.361.280.991.070.990.570.750.52
Enterprise Value
1,722.74M1,284.19M1,209.33M829.17M733.34M918.14M916.36M813.66M694.95M595.44M529.44M357.71M552.85M396.37M471.66M429.43M363.84M200.41M273.25M316.77M
EV to EBIT
7.487.716.598.208.888.896.376.264.728.346.918.3910.274.2223.12
EV to EBITDA
6.957.115.967.337.867.775.595.404.006.845.145.916.152.516.29
Market Capitalization
1,962.57M1,521.95M1,439.70M1,076.05M1,021.76M1,213.59M1,216.55M1,120.74M1,025.37M923.78M861.87M722.60M680.39M521.88M568.50M521.30M363.84M311.92M397.14M273.44M
Price to FCFP/FCF
18.0914.0518.6915.0410.9314.0614.1613.8118.2615.4214.5411.0113.3610.6311.1527.8910.0610.199.11
EV to FCF
15.8811.8615.7011.597.8410.6410.6610.0312.389.948.935.4510.868.079.2522.9710.066.556.27
EV to CFO
14.2110.5912.509.387.069.469.969.569.847.897.164.409.066.747.4813.6216.2812.059.85
Return Ratios
Return on Sales [ROS]ROS
12.12%11.10%9.70%10.81%10.24%8.25%10.83%8.38%7.79%3.84%6.28%7.09%0.57%5.54%-8.96%
Return on Capital Employed [ROCE]ROCE
41.15%36.34%29.18%23.77%21.06%18.69%18.04%16.05%14.11%11.63%9.40%9.08%6.84%1.92%
Return on Invested Capital [ROIC]ROIC
29.76%11.56%9.80%8.20%6.72%5.46%5.59%2.90%0.00%
Return on Assets [ROA]ROA
20.85%19.49%14.29%10.48%9.74%9.15%9.00%9.90%8.89%7.36%7.24%5.93%4.66%4.70%2.40%-2.39%-4.89%
Return on Equity [ROE]ROE
30.37%28.56%20.36%14.32%13.27%12.36%11.77%12.69%11.26%9.17%9.03%7.90%6.56%6.57%3.32%-3.22%-6.56%

Usana Health Sciences Ratios API

Pull Usana Health Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=USNA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY